Molecular diagnostics in pathology

被引:9
|
作者
Stenzinger, A. [1 ]
Penzel, R. [1 ]
Endris, V. [1 ]
Weichert, W. [1 ,2 ]
机构
[1] Univ Klinikum Heidelberg, Inst Pathol, D-69120 Heidelberg, Germany
[2] Natl Ctr Tumorerkrankungen, Heidelberg, Germany
关键词
pathology; molecular diagnostics; tissue; pathogenic organisms; immunohistochemistry; sequencing; mutations; oncology; CANCER; BIOMARKERS; GENOMICS;
D O I
10.1055/s-0033-1343106
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tissue-based molecular diagnostics is a fast growing diagnostic field, which already complements morphologic classifications in many cases. Pathology based molecular diagnosis is performed almost exclusively on paraffin embedded material and always in conjunction with histopathology. Besides the classic field of tissue based detection of pathogenic organisms such as bacteria, viruses and fungi, molecular diagnostics of tumor tissue is one of the current hot topics in oncology. In this context the detection of predictive molecular biomarkers, such as specific mutations, allows patient stratification for individually tailored treatment strategies and thereby is one of the key components of individualized patient care in oncology. The rapidly growing number of clinically relevant predictive biomarkers together with impressive technical advances, specifically the development of massive parallel sequencing, will modify the care of patients with malignant diseases. Pathology, therefore, has returned in the very center of interdisciplinary patient care. © Georg Thieme Verlag KG · Stuttgart · New York.
引用
收藏
页码:1061 / 1068
页数:8
相关论文
共 50 条
  • [31] Advances in Lymphoma Molecular Diagnostics
    Kos, Igor Age
    Thurner, Lorenz
    Bittenbring, Joerg Thomas
    Christofyllakis, Konstantinos
    Kaddu-Mulindwa, Dominic
    DIAGNOSTICS, 2021, 11 (12)
  • [32] The progress of molecular diagnostics of osteosarcoma
    Li, Chengjun
    Cong, Yu
    Liu, Xiaozhou
    Zhou, Xing
    Zhou, Guangxin
    Lu, Meng
    Shi, Xin
    Wu, Sujia
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2016, 21 : 20 - 30
  • [33] Establishing the Evidence Bar for Molecular Diagnostics in Personalised Cancer Care
    Schneider, Daniel
    Bianchini, Giampaolo
    Horgan, Denis
    Michiels, Stefan
    Witjes, Wim
    Hills, Robert
    Plun-Favreau, Juliette
    Brand, Angela
    Lawler, Mark
    PUBLIC HEALTH GENOMICS, 2015, 18 (06) : 349 - 358
  • [34] RAS testing of colorectal carcinoma-a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Group
    Wong, Newton A. C. S.
    Gonzalez, David
    Salto-Tellez, Manuel
    Butler, Rachel
    Diaz-Cano, Salvador J.
    Ilyas, Mohammad
    Newman, William
    Shaw, Emily
    Taniere, Philippe
    Walsh, Shaun V.
    JOURNAL OF CLINICAL PATHOLOGY, 2014, 67 (09) : 751 - 757
  • [35] New developments in the pathology and molecular biology of retroperitoneal sarcomas
    Watson, Sarah
    Gruel, Nadege
    Le Loarer, Francois
    EJSO, 2023, 49 (06): : 1053 - 1060
  • [36] The roles of small extracellular vesicles in lung cancer: Molecular pathology, mechanisms, diagnostics, and therapeutics
    Liu, Yi
    Xia, Yiqiu
    Smollar, Jillian
    Mao, Wenjun
    Wan, Yuan
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (01):
  • [37] Advanced diagnostics applied to fish liver tumours: Relating pathology to underlying molecular aetiology
    Lerebours, Adelaide
    Bignell, John P.
    Stentiford, Grant D.
    Feist, Stephen W.
    Lyons, Brett P.
    Rotchell, Jeanette M.
    MARINE POLLUTION BULLETIN, 2013, 72 (01) : 94 - 98
  • [38] Renal cell carcinoma: from pathology to molecular neoplastic processes
    Perrin, C.
    Edeline, J.
    Vigneau, C.
    Patard, J. -J.
    Rioux-Leclercq, N.
    ONCOLOGIE, 2009, 11 (05) : 254 - 259
  • [39] Molecular biology in pancreatic ductal adenocarcinoma: implications for future diagnostics and therapy
    Soreide, Kjetil
    Primavesi, Florian
    Labori, Knut J.
    Watson, Martin M.
    Staettner, Stefan
    EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, 2019, 51 (03): : 126 - 134
  • [40] Molecular biology in pancreatic ductal adenocarcinoma: implications for future diagnostics and therapy
    Kjetil Søreide
    Florian Primavesi
    Knut J. Labori
    Martin M. Watson
    Stefan Stättner
    European Surgery, 2019, 51 : 126 - 134